Zhongguo shi yan xue ye xue za zhi

Keyphrases

Publications

volume 32, number 4, 2024

Qiang Ma, Rong-Hua Hu, Hong Zhao, Xiao-Xi Lan, Yi-Xian Guo, Xiao-Li Chang, Wan-Ling Sun, Li Su, Wu-Han Hui
[Genetic Variation of SH2B3 in Patients with Myeloid Neoplasms]. Zhongguo shi yan xue ye xue za zhi 32 (4) (2024)
Qiao-Lin Chen, You-Fan Feng, Yuan Fu, Fei Liu, Wen-Jie Zhang, Yang Chen, Xiao-Fang Wei, Qi-Ke Zhang
[Clinical Characteristics and Prognosis of Patients with Primary Bone Marrow Lymphoma]. Zhongguo shi yan xue ye xue za zhi 32 (4) (2024)
Xue Xu, Zong-Yuan Ye
[Prognostic Value of LMR and CD163 + TAM for Patients with Diffuse Large B Cell Lymphoma]. Zhongguo shi yan xue ye xue za zhi 32 (4) (2024)
Shu-Ming Huang, Xiao-Mei Lin, Hui-Wei Tang, Jia Zeng
[The Causes of Platelet Aggregation in Version 6.4 Trima Accel Automated Blood Collection System and the Comparison of Two Intervention Measures]. Zhongguo shi yan xue ye xue za zhi 32 (4) (2024)
Cai-Hong Zhang, Rui-Jun Su, Bin-Tao Huang, Zhi-Ling Wang
[The Relationship Between Serum CysC, β2-MG and the Efficacy of Demethylation Therapy in Patients with Acute Myeloid leukemia]. Zhongguo shi yan xue ye xue za zhi 32 (4) (2024)
Yue Yang, Jian-Xin He
[Inhibition Effect of Resveratrol on Spontaneous Senescence of Human Bone Marrow Derived Mesenchymal Stem Cells]. Zhongguo shi yan xue ye xue za zhi 32 (4) (2024)
Yue-Fei Wang, Bao-Guo Chen, Rui Zheng, Yi-Ni Yu
[Expression and Significance of PD-1/PD-L1 in MDS Blast Cells, T Lymphocyte Cell Subsets and Treg Cells]. Zhongguo shi yan xue ye xue za zhi 32 (4) (2024)
Cong Zhang, Cai Sun, De-Zhen Wang, Zhan-Wei Liu, Ting Fang
[Efficacy and Safety of Reduced Dose Azacitidine in the Treatment of Elderly Patients with Myelodysplastic Syndromes]. Zhongguo shi yan xue ye xue za zhi 32 (4) (2024)
Rui-Xue Ju, Feng-Qiang Sun, Yu-Hui Wang
[Effect of Flow Cytometric MRD Detection at Different Time Points during AML Chemotherapy on Prognosis]. Zhongguo shi yan xue ye xue za zhi 32 (4) (2024)
Yue Ma, Jia-Jia Li
[Expression and Clinical Significance of LncRNA HEIH in Patients with Acute Myeloid Leukemia]. Zhongguo shi yan xue ye xue za zhi 32 (4) (2024)
Xi Qi, Lin-Bao Gao, Sheng-Xia Chen
[Relative Quantification for Obtaining the IgG Blood Group Antibodies in Plasma by the Absorption and Elution Test]. Zhongguo shi yan xue ye xue za zhi 32 (4) (2024)
Yan-Quan Liu, Shao-Peng Chen, Yue Yin, Jian-Zhen Shen, Min-Juan Zeng
[Aberrant Expression of Small Nucleolar RNA SNORA63 and Its Clinical Significance in Patients with Acute Leukemia]. Zhongguo shi yan xue ye xue za zhi 32 (4) (2024)
Yi-Zhe Zheng, Dong-Dong Li, Geng-Wei Yan, Bao-Jian Wang, Ke Wang, Lei Wang, Shao-Duo Yan, Yan-Hong Li, Qiu-Xia Fu, Zhen-Wei Sun
[Preparation Method and Quality Evaluation of Novel Frozen Human Platelets]. Zhongguo shi yan xue ye xue za zhi 32 (4) (2024)
Hong-Xia He, Yan-Yan Xie, Qing-Yun Sun, Lin-Hong Wang, Yi-Wen Zhu, Jie Li, Xin Wang, Zhao-Ling Deng, Mei-Rong Yang, Zhen-Yu Yan
[Clinical Significance of the Levels of Peripheral Blood Tregs and Cytokines IL-35, TGF-β and IL-10 in Hemophilia A Patients with FⅧ Inhibitor]. Zhongguo shi yan xue ye xue za zhi 32 (4) (2024)
Meng-Ya Zhao, Yu Qiu, Jing-Feng Liu, Dong-Chen Guo, Jin Lin
[Clinical Characteristics Analysis of EBV-associated Hemophagocytic Lymphohistiocytosis Patients with Acute Kidney Injury]. Zhongguo shi yan xue ye xue za zhi 32 (4) (2024)
Yan-Ling Li, Xiao-Qi Qin, Lu-Yao Guo, Xiao-Xu Hou, Yao Chao, Yan-Ping Ma
[Correlation of CD4 + /CD8 + Ratio in Peripheral Blood with Prognosis of Mantle Cell Lymphoma]. Zhongguo shi yan xue ye xue za zhi 32 (4) (2024)
Lan Yang, Li-Xia Cao, Hui-Juan Ren, Yan-Qiu Han
[Primary Extranodal Diffuse Large B-Cell Lymphoma in the Rituximab Era: a Single-Center Retrospective Analysis]. Zhongguo shi yan xue ye xue za zhi 32 (4) (2024)
Xiao-Jun Chen, Su-Xia Lin, Dong-Hui Gan, Jian-Zhen Shen, Yu-Min Fu, Yue Yin, Min-Juan Zeng, Yan-Quan Liu
[Clinical Features and Prognosis of Secondary Intestinal Diffuse Large B-Cell Lymphoma]. Zhongguo shi yan xue ye xue za zhi 32 (4) (2024)
Yi Chen, Yue-Ru Ji, Jing-Yi Zhang, Wei-Wei Qin, Cang-Chun Liu, Li Liu, Xue-Qian Yan
[Clinical Characteristics and Prognosis of Myelodysplastic Syndromes Patients with RUNX1 Gene Mutation]. Zhongguo shi yan xue ye xue za zhi 32 (4) (2024)
Hong-Bin Zhao, Jia-Jia Qiao, Xue-Hua He
[Correlation Analysis between Serum Fibronectin 3 Levels and Early Severe Bleeding in Patients with Newly Diagnosed Acute Promyelocytic Leukemia]. Zhongguo shi yan xue ye xue za zhi 32 (4) (2024)
Hui-Xia Guo, Shu-Ya Cao, Yi-Juan Chen, Qian Li, Yue Wu, Yu-Xi Shang, Li-Ru Wang
[Comparison of Blood Oxygen Saturation Detection Methods in Patients with Hyperleukocytic Acute Leukemia]. Zhongguo shi yan xue ye xue za zhi 32 (4) (2024)
Yong-Liang Zheng, Ting Ding, Xiao-Fang Xiao, Si Dong, Jun-Quan Zeng, Yi-Jian Chen
[Clinical Study of Venetoclax Combined with Azacitidine in the Treatment of Patients with Adult Acute Myeloid Leukemia]. Zhongguo shi yan xue ye xue za zhi 32 (4) (2024)
Lu-Hui Lin, Sun-Qiao Gao, Xu-Qiao Mei, Da-Yi Lin, Yi-Feng Chen, Su-Dan Lin, Li-Hong Zhuang, Cong-Meng Lin
[Effect of Selinexor on Proliferation and Apoptosis of Acute Myeloid Leukemia Kasumi-1 Cells]. Zhongguo shi yan xue ye xue za zhi 32 (4) (2024)
Xue Bai, Yan-Ping Wu, Zhong-Yu Li, Xiao-Feng Chen, Meng Wang, Jia-Jia Li
[Expression of lncRNA UCA1 in Acute Myeloid Leukemia Patients and Its Clinical Significance]. Zhongguo shi yan xue ye xue za zhi 32 (4) (2024)
Hong Liu, Zhi Li, Yu-Ye Shi, Shan-Dong Tao, Chun-Ling Wang, Liang Yu
[Analysis of Factors Influencing Overall Survival and Prognosis of AML Patients Over 50 Years Old]. Zhongguo shi yan xue ye xue za zhi 32 (4) (2024)
Li-Min Duan, Guang-Li Yin, Tian Tian, Ju-Juan Wang, Xin Gao, Wan-Ying Cheng, Zi-Wei Fang, Hong-Xia Qiu, Ji Xu
[Effect of Plasma Epstein-Barr Virus Nucleic Acid Loads on the Clinical Features and Prognosis in Adult Secondary Hemophagocytic Lymphohistiocytosis]. Zhongguo shi yan xue ye xue za zhi 32 (4) (2024)
Yong-Qing Zhou, Xiao-Yu Su, Qian Zhao, Zhao-Qun Deng
[Expression and Function of circ_0073585 in Acute Myeloid Leukemia]. Zhongguo shi yan xue ye xue za zhi 32 (4) (2024)
Zhi-Wen Xiao, Ling Qi, Fei Li
[Application and Research Progress of Selinexor in Hematologic Tumors Other Than Multiple Myeloma --Review]. Zhongguo shi yan xue ye xue za zhi 32 (4) (2024)
Yang Xue, Chao Li, Wen-Long Xin, Xing Zeng, Tao Ma, Fang-Fang Chen, Chen Cao, Hong-Jun Gao
[Identification of Novel Variations in Exon 1 of ABO Blood Group Gene]. Zhongguo shi yan xue ye xue za zhi 32 (4) (2024)
Shao-Yan Si, Ya-Ya Qin, Ying-Ying Wu, Xiao-Yu Ma, Ying Shang, Shu-Jun Song, Yan-Chuan Guo
[Effect of Collagen Peptides on Function of Mouse T Lymphocytes under Simulated Microgravity]. Zhongguo shi yan xue ye xue za zhi 32 (4) (2024)
Li-Fang Liang, Xiu-Ning Huang, Dong-Ming Li, Bi-Yan Chen, Xiang Chen, Zhen-Ren Peng, Sheng He
[Analysis of Thalassemia Gene Mutation Types and Ethnic Distribution Characteristics in Hechi Area, Guangxi]. Zhongguo shi yan xue ye xue za zhi 32 (4) (2024)
Ya-Li Zhang, Jing-Nan Hao, Meng-Meng Sun, Xiao-Ying Xing, Shu-Kai Qiao
[Etiology, Clinical Characteristics and Prognosis of Secondary Hemophagocytic Syndrome]. Zhongguo shi yan xue ye xue za zhi 32 (4) (2024)
Lan-Xiang Liu, Jing Wang, Li Wang, Lin Liu, Xin Wang, Hong-Bin Zhang, Xiao-Qiong Tang, Yi-Ying Xiong
[Clinical Analysis of Epstein-Barr Virus Infection after Allogeneic Hematopoietic Stem Cell Transplantation]. Zhongguo shi yan xue ye xue za zhi 32 (4) (2024)
Bin Fan, Chun-Hui Yang, Bin Li, Li-Min Chen
[Current Status of Application and Quality Evaluation of Commercial Platelet Pathogen Reduction Technology --Review]. Zhongguo shi yan xue ye xue za zhi 32 (4) (2024)
Qiang-An Jing, Chao-Ting Zhou, Yun-Yi Wu, Xia Ke, Xiang-Min Tong
[Thiotert Induces Myelodysplastic Syndromes Cells Apoptosis by Activating Oxidative Stress]. Zhongguo shi yan xue ye xue za zhi 32 (4) (2024)
Hui-Jian Xiao, Qiu-Ju Wang, Shuang Wu, Xu-Bo Dai, Yue-Peng Zhuang
[Correlation between Morphological Typing and Monoclonality of Bone Marrow Plasma Cells and Its Diagnostic Value for High-Risk Smoldering Multiple Myeloma]. Zhongguo shi yan xue ye xue za zhi 32 (4) (2024)
Yang-Yang Zhao, You-Fan Feng, Xiao-Fang Wei, Qing-Fe Li, Xiu-Juan Huang, Yuan Fu, Qi-Ke Zhang
[Risk Prediction and Risk Factors of Thrombotic/Bleeding Events in Patients with Myeloproliferative Neoplasm]. Zhongguo shi yan xue ye xue za zhi 32 (4) (2024)
Yan-Zhen Wang, Zheng-Rong Liu
[Relationship between the Age of Diagnosis and Clinical Outcomes in Children with Chronic Immune Thrombocytopenia]. Zhongguo shi yan xue ye xue za zhi 32 (4) (2024)
Lan-Xin Zhang, Yi-Zhi Jiang, Li-Jun Qiu, Dong-Ping Huang
[Quantitative Detection and Integrality Analysis of Plasma Circulating Cell-Free DNA in Multiple Myeloma]. Zhongguo shi yan xue ye xue za zhi 32 (4) (2024)
Ya-Ping Wang, Xue-Ya Zhang
[Clinical Analysis of PD-1 Inhibitor Combined with Lenalidomide in Treatment of Relapsed CD5 + Diffuse Large B-Cell Lymphoma]. Zhongguo shi yan xue ye xue za zhi 32 (4) (2024)
Ya-Jiao Liu, Li Sheng, Jing-Fen Zhou, Hai-Ying Hua
[Systemic Inflammatory Markers Can Improve Survival Prediction of Patients with Diffuse Large B-Cell Lymphoma: Model Development and Evaluation]. Zhongguo shi yan xue ye xue za zhi 32 (4) (2024)
Yang-Gan Luo, Zi-Han Lu, Han-Jing Liao, Dou-Dou Hao, Man-Jing Huang, Zhi-Xiang Zhu
[Study on the Experimental Methodology of Plasma Clot Retraction]. Zhongguo shi yan xue ye xue za zhi 32 (4) (2024)
Li Sheng, Ya-Jiao Liu, Jing-Fen Zhou, Hong-Ying Chao, Hai-Ying Hua, Xin Zhou, Xiao-Hong Zhao
[Characteristic Analysis of Adult Acute Myeloid Leukemia Patients with PTPN11 Gene Mutation]. Zhongguo shi yan xue ye xue za zhi 32 (4) (2024)
Yu-Ang Gao, Qian-Yu Zhang, Xin Li, Shen-Yu Wang, Ji-Hui Li, Yang Xue, Chang-Yan Li, Hong-Mei Ning
[Dobutamine Enhances the Targeted Inhibitory Effect of Quizartinib on FLT3-ITD Mutant Acute Myeloid Leukemia]. Zhongguo shi yan xue ye xue za zhi 32 (4) (2024)
Cai-Feng Liao, Hu-Rong Lai, Jian Li
[Research Progress on the Influence of Blood Tumor Microen-vironment on the Efficacy and the Adverse Reactions of CAR-T Cell Immunotherapy--Review]. Zhongguo shi yan xue ye xue za zhi 32 (4) (2024)
Hao Ji, Xiao-Sui Ling, Zeng-Zheng Li, Tong-Hua Yang
[Research Progress in Diagnosis and Treatment of Acute Leukemia Complicated with Pulmonary Infection--Review]. Zhongguo shi yan xue ye xue za zhi 32 (4) (2024)
Yu-Xin Gong, Zhuo-Jing Yang, Ji-Min Cao, Hui-Min Liu
[Effect of Csn-B Combined with Imatinib on Apoptosis of Chronic Myeloid Leukemia Cells through Nur77/Pim-1/Drp1 Pathway]. Zhongguo shi yan xue ye xue za zhi 32 (4) (2024)
Yang Chen, Yan-Yan Xie, Yu Fang, Ming Hong, Wen-Jie Liu, Xuan Zhou, Wei Zhang, Jin-Ning Shi, Si-Xuan Qian
[Clinical Characteristics and Prognostic Relevance of Co-Mutated Genes in Acute Myeloid Leukemia Patients with FLT3 Mutations]. Zhongguo shi yan xue ye xue za zhi 32 (4) (2024)
Hui-Juan Chen, Yang Cao, Ying-Jie Miao, Yi-Fang Zhou, Yue Liu, Wei-Ying Gu
[Prognostic Value of DTA Mutations in Patients with Newly Diagnosed Acute Myeloid Leukemia]. Zhongguo shi yan xue ye xue za zhi 32 (4) (2024)
Huan Su, Ning Wen, Jie Xiang, Neng-Yong Wang
[Changes in Serum HOXA9 , PCⅢ, SE-CAD Levels in AML Patients after Chemotherapy with DCAG Regimen and Their Relationship with Prognosis]. Zhongguo shi yan xue ye xue za zhi 32 (4) (2024)